CO2019002624A2 - Compuestos antibióticos - Google Patents
Compuestos antibióticosInfo
- Publication number
- CO2019002624A2 CO2019002624A2 CONC2019/0002624A CO2019002624A CO2019002624A2 CO 2019002624 A2 CO2019002624 A2 CO 2019002624A2 CO 2019002624 A CO2019002624 A CO 2019002624A CO 2019002624 A2 CO2019002624 A2 CO 2019002624A2
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- antibiotic compounds
- infections
- gram
- treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000003115 biocidal effect Effects 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1614314.1A GB201614314D0 (en) | 2016-08-22 | 2016-08-22 | Antibiotic compounds |
| PCT/GB2017/052478 WO2018037223A1 (en) | 2016-08-22 | 2017-08-22 | Antibiotic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2019002624A2 true CO2019002624A2 (es) | 2019-05-31 |
Family
ID=57045563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2019/0002624A CO2019002624A2 (es) | 2016-08-22 | 2019-03-21 | Compuestos antibióticos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20190194179A1 (enExample) |
| EP (1) | EP3500567A1 (enExample) |
| JP (1) | JP2019528291A (enExample) |
| KR (1) | KR20190046894A (enExample) |
| CN (1) | CN109923111A (enExample) |
| AU (1) | AU2017316742A1 (enExample) |
| BR (1) | BR112019003427A2 (enExample) |
| CA (1) | CA3034000A1 (enExample) |
| CO (1) | CO2019002624A2 (enExample) |
| EA (1) | EA201990551A1 (enExample) |
| GB (1) | GB201614314D0 (enExample) |
| MX (1) | MX2019001978A (enExample) |
| PH (1) | PH12019500360A1 (enExample) |
| SG (1) | SG11201901374WA (enExample) |
| WO (1) | WO2018037223A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3636645A1 (de) | 2018-10-11 | 2020-04-15 | Bayer Aktiengesellschaft | Verfahren zur herstellung schwefel-substituierter pyridinderivate |
| KR102793543B1 (ko) | 2018-10-11 | 2025-04-11 | 바이엘 악티엔게젤샤프트 | 이미다졸 유도체의 제조 방법 |
| TWI841671B (zh) | 2019-01-24 | 2024-05-11 | 日商第一三共股份有限公司 | 具有取代基之脲化合物 |
| US20220125763A1 (en) | 2019-02-22 | 2022-04-28 | Anifera Limited | Compositions providing enhanced antibacterial activity against gram-positive bacteria and use thereof |
| CN111808093B (zh) * | 2019-04-12 | 2023-05-16 | 中国医学科学院医药生物技术研究所 | 一种新德里金属-β-内酰胺酶-1抑制剂 |
| BR112021020055A2 (pt) * | 2019-04-12 | 2021-12-07 | Mitobridge Inc | Indutores de hmox1 |
| US12528798B2 (en) | 2019-10-29 | 2026-01-20 | Lg Chem, Ltd. | Compound for crop protectant |
| CN116528873B (zh) * | 2020-11-19 | 2025-08-22 | A&J科学有限公司 | 新型化合物、其制造方法及包含其的抗生素组合物 |
| CN113185475A (zh) * | 2021-04-29 | 2021-07-30 | 江苏永凯化学有限公司 | 一种高效低污染的精恶唑禾草灵生产工艺 |
| KR20240016304A (ko) * | 2021-05-31 | 2024-02-06 | 장슈 야홍 메디텍 코퍼레이션 리미티드 | 7-니트로-8-하이드록시퀴놀린 유도체, 이의 제조 방법 및 이의 의학적 용도 |
| KR102754999B1 (ko) * | 2022-01-06 | 2025-01-21 | 충남대학교산학협력단 | 신규한 화합물 및 이를 포함하는 결핵균 또는 비결핵항산균 감염질환 치료용 약제학적 조성물 |
| JP2025522339A (ja) * | 2022-06-01 | 2025-07-15 | クダ セラピューティクス インコーポレイテッド | イミダゾピリジン及びオキサゾロピリジン誘導体及びその類似体、その調製方法、ＨＩＦ－１／２ａ経路阻害の方法、並びに、フェロトーシスの誘導 |
| JP2026505647A (ja) * | 2022-12-16 | 2026-02-17 | インベンション・セラピューティクス・インコーポレイテッド | ベンゾイミダゾール誘導体 |
| KR102840252B1 (ko) * | 2023-04-27 | 2025-07-30 | 한국화학연구원 | 시아노벤즈이미다졸 유도체, 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물 |
| CN117003710A (zh) * | 2023-07-19 | 2023-11-07 | 镇江先锋植保科技有限公司 | 一种2-巯基-6-氯苯并恶唑的制备方法 |
| AU2024331213A1 (en) * | 2023-09-01 | 2026-04-16 | Immvention Therapeutix, Inc. | Substituted benzoxazolylamino benzoxazoles |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8604217B2 (en) * | 2009-11-12 | 2013-12-10 | Selvita S.A. | Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| JP5786402B2 (ja) * | 2011-03-29 | 2015-09-30 | コニカミノルタ株式会社 | 光学フィルム、及びそれを用いた偏光板、液晶表示装置 |
| WO2016039939A1 (en) * | 2014-09-09 | 2016-03-17 | Ptc Therapeutics, Inc. | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds |
-
2016
- 2016-08-22 GB GBGB1614314.1A patent/GB201614314D0/en not_active Ceased
-
2017
- 2017-08-22 BR BR112019003427-7A patent/BR112019003427A2/pt not_active Application Discontinuation
- 2017-08-22 US US16/327,286 patent/US20190194179A1/en not_active Abandoned
- 2017-08-22 EA EA201990551A patent/EA201990551A1/ru unknown
- 2017-08-22 SG SG11201901374WA patent/SG11201901374WA/en unknown
- 2017-08-22 AU AU2017316742A patent/AU2017316742A1/en not_active Withdrawn
- 2017-08-22 CN CN201780063473.8A patent/CN109923111A/zh active Pending
- 2017-08-22 KR KR1020197008269A patent/KR20190046894A/ko not_active Withdrawn
- 2017-08-22 MX MX2019001978A patent/MX2019001978A/es unknown
- 2017-08-22 WO PCT/GB2017/052478 patent/WO2018037223A1/en not_active Ceased
- 2017-08-22 JP JP2019510688A patent/JP2019528291A/ja not_active Withdrawn
- 2017-08-22 CA CA3034000A patent/CA3034000A1/en not_active Abandoned
- 2017-08-22 EP EP17761308.0A patent/EP3500567A1/en not_active Withdrawn
-
2019
- 2019-02-20 PH PH12019500360A patent/PH12019500360A1/en unknown
- 2019-03-21 CO CONC2019/0002624A patent/CO2019002624A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201901374WA (en) | 2019-03-28 |
| EP3500567A1 (en) | 2019-06-26 |
| PH12019500360A1 (en) | 2019-11-11 |
| US20190194179A1 (en) | 2019-06-27 |
| GB201614314D0 (en) | 2016-10-05 |
| KR20190046894A (ko) | 2019-05-07 |
| AU2017316742A1 (en) | 2019-04-11 |
| BR112019003427A2 (pt) | 2019-05-21 |
| CA3034000A1 (en) | 2018-03-01 |
| EA201990551A1 (ru) | 2019-12-30 |
| MX2019001978A (es) | 2019-08-01 |
| JP2019528291A (ja) | 2019-10-10 |
| CN109923111A (zh) | 2019-06-21 |
| WO2018037223A1 (en) | 2018-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500360A1 (en) | Antibiotic compounds | |
| EA201691766A1 (ru) | Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций | |
| CL2020001147A1 (es) | Compuestos antibacterianos | |
| CL2017002176A1 (es) | Identificación bacteriana y prueba de susceptibilidad antimicrobiana. | |
| SV2017005462A (es) | Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc | |
| CR20140125A (es) | Compuestos antibacterianos y métodos para su uso | |
| BR112017007438A2 (pt) | derivados bi aromáticos básicos antibacterianos com substituição de aminoalcoxi | |
| CL2019000053A1 (es) | Bacterias probióticas para peces. | |
| MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
| MX2019013291A (es) | Compuestos y metodos para tratar infecciones bacterianas. | |
| CL2017001276A1 (es) | Derivados de benzotiazol antibacterianos | |
| PH12016501532A1 (en) | Antibacterial combinations comprising polymyxin | |
| MX2018006199A (es) | Antibioticos de amplio espectro macrociclico. | |
| MX2017015988A (es) | Derivados de manosa para tratar infecciones bacterianas. | |
| ECSP18060284A (es) | Tratamiento para microorganismos que contienen quitina | |
| BR112018071101A2 (pt) | derivados bioaromáticos antibacterianos com substituição de oxetana-3-iloxi | |
| UY36043A (es) | COMPUESTOS ORGÁNICOS DE MONOBACbTAM PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS | |
| CR20160412A (es) | Compuestos organicos de monobactam para el tratamiento de infecciones bacterianas |